The Latest Trading Price of Biofil Chemicals & Pharmaceuticals Ltd is ₹ 32.22 as of 18 May 15:30
. The P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd is 0 as of March 2024
.The P/E Ratio of Shree Ganesh Remedies Ltd is 30.5 as of March 2024
. The Market Cap of Biofil Chemicals & Pharmaceuticals Ltd is ₹ 0 crore as of March 2024
.The Market Cap of Shree Ganesh Remedies Ltd is ₹ 801.21 crore as of March 2024
. The revenue of Biofil Chemicals & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Shree Ganesh Remedies Ltd for the Mar '26 is ₹ 34.22 crore as compare to the Dec '25 revenue of ₹ 21.76 crore. This represent the growth of 57.26% The ebitda of Biofil Chemicals & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Shree Ganesh Remedies Ltd for the Mar '26 is ₹ 12.4 crore as compare to the Dec '25 ebitda of ₹ 7.39 crore. This represent the growth of 67.79% The net profit of Biofil Chemicals & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0%
The net profit of Shree Ganesh Remedies Ltd changed from ₹ 4.65 crore to ₹ 6.27 crore over 8 quarters. This represents a CAGR of 16.12%
The Dividend Payout of Biofil Chemicals & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Shree Ganesh Remedies Ltd changed from 17.97 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .
About Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 Jan.'85 for manufacturing and trading of Pharmaceuticals products.
Later on, the Company was converted into a Public Limited Company on 7 May '92.
The Company deals in providing job work facility in respect of manufacturing of pharmaceuticals drug.
It runs the business via two unit viz Pharmaceutical Division & Chemicals Division.
In Feb.'96, the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively, both aggregating Rs 23.21 cr, to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations.
The company currently manufactures pharmaceutical formulations like injections, capsules, eye-drops and dry syrups at its plant located in Indore.
About Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Limited was originally incorporated as a Private Limited Company with the name 'Shree Ganesh Remedies Private Limited' at Ahmedabad, Gujarat on April 27, 1995.
Subsequently the Company was converted into a Public Limited and the name of the Company was changed to 'Shree Ganesh Remedies Limited' on July 28, 2017.
The Company, a part of Ganesh Group has carved for itself a niche in the industry of manufacturing pharmaceutical intermediates and fine chemicals.
Shree Ganesh Remedies is a ISO 9001:2015, ISO 14001:2015 BS and OHSAS 18001:2007 certified Company and is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry.
The Company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral.
FAQs for the comparison of Biofil Chemicals & Pharmaceuticals Ltd and Shree Ganesh Remedies Ltd
Which company has a larger market capitalization, Biofil Chemicals & Pharmaceuticals Ltd or Shree Ganesh Remedies Ltd?
Market cap of Biofil Chemicals & Pharmaceuticals Ltd is 52 Cr while Market cap of Shree Ganesh Remedies Ltd is 712 Cr
What are the key factors driving the stock performance of Biofil Chemicals & Pharmaceuticals Ltd and Shree Ganesh Remedies Ltd?
The stock performance of Biofil Chemicals & Pharmaceuticals Ltd and Shree Ganesh Remedies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Biofil Chemicals & Pharmaceuticals Ltd and Shree Ganesh Remedies Ltd?
As of May 18, 2026, the Biofil Chemicals & Pharmaceuticals Ltd stock price is INR ₹32.22. On the other hand, Shree Ganesh Remedies Ltd stock price is INR ₹554.8.
How do dividend payouts of Biofil Chemicals & Pharmaceuticals Ltd and Shree Ganesh Remedies Ltd compare?
To compare the dividend payouts of Biofil Chemicals & Pharmaceuticals Ltd and Shree Ganesh Remedies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.